In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.
Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.
The White House seeks to update how biotechnology products are regulated.
The American Society of Human Genetics has issued a position statement on genetic testing of children.
In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.
The BabySeq project to study the risks and benefits of sequencing newborns is underway.
A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.
A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.
In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.
IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.
A company says it can generate likenesses of people based on their genetic profiles.
In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.
At her blog, Sally Rockey dives into National Institutes of Health funding data.
The New York Times examines ethics and China's push to lead biomedical research.
Researchers report that what scents someone picks up can reflect their complement of immune genes.
In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.
US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.
Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.
An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.
In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.
A set of guidelines aimed at increasing transparency in basic science publications is described in Science.
A jury awards $2.25 million in the case of the 'devious defecator,' which was brought under the US Genetic Information Nondiscrimination Act.
A provision of the US 21st Century Cures Act may cost $869 million between 2016 and 2025, according to Pharmalot.
In Science this week: how Cas9 works, DNA in biofluids to detect head and neck cancers, and more.
The New York Times looks into the genetic testing industry, focusing on the case of Renaissance RX.